Jeremy S. Abramson, MD

Jeremy Abramson, MD, is a professor of medicine at Harvard Medical School and director of the Center for Lymphoma at the Mass General Cancer Center.

Articles by Jeremy S. Abramson, MD

Dr Abramson on ASCO 2025 DLBCL Updates: What's New?

ByJeremy S. Abramson, MD

June 23rd 2025

Jeremy S. Abramson, MD, discusses pivotal advancements in DLBCL from the 2025 American Society of Clinical Oncology Annual Meeting.

Glofitamab and GemOx Shows Durable Benefit in R/R DLBCL

ByJeremy S. Abramson, MD

June 17th 2025

Jeremy S. Abramson, MD, discusses the significant 2-year follow-up results from the phase 3 STARGLO trial in DLBCL.

Abramson Discusses Liso-Cel as a Transformative Therapy in LBCL

ByJeremy S. Abramson, MD

December 5th 2023

Jeremy Abramson, MD, discusses what the findings from the phase 3 TRANSFORM study of lisocabtagene maraleucel mean for patients with relapsed large B-cell lymphoma.

Liso-Cel Shows Clinical Benefit in Relapsed/Refractory LBCL

ByJeremy S. Abramson, MD

October 14th 2023

Jeremy Abramson, MD, discusses findings from the TRANSFORM study of lisocabtagene maraleucel vs standard of care treatment in patients with relapsed or refractory large B-cell lymphoma.